Chylomicronaemia-current diagnosis and future therapies, Nat Rev Endocrinol, vol.11, pp.352-62, 2015. ,
Genetic bases of hypertriglyceridemic phenotypes, Curr Opin Lipidol, vol.22, pp.247-53, 2011. ,
A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias, Nat Clin Pract Endocrinol Metab, vol.4, pp.608-626, 2008. ,
Pathophysiology of hypertriglyceridemia, Biochim Biophys Acta, vol.1821, pp.826-858, 2012. ,
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association, Circulation, vol.123, pp.2292-333, 2011. ,
Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy, J Clin Endocrinol Metab, vol.82, pp.791-797, 1997. ,
Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia, Atherosclerosis, vol.208, pp.324-331, 2010. ,
Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody, J Clin Endocrinol Metab, vol.99, pp.1525-1555, 2014. ,
Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia, N Engl J Med, vol.376, pp.1647-58, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01608620
Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia, J Clin Endocrinol Metab, vol.90, pp.3995-4003, 2005. ,
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome, J Clin Endocrinol Metab, vol.96, pp.3302-3309, 2011. ,
Rituximab in autoimmune diseases, Aust Prescr, vol.39, pp.131-135, 2016. ,
Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects, PLoS One, vol.9, p.99721, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01859439
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis, Ann Rheum Dis, vol.70, pp.909-929, 2011. ,
Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story, Eur J Intern Med, vol.26, pp.659-65, 2015. ,
Autoimmune hyperchylomicronemia, N Engl J Med, vol.320, pp.1255-1264, 1989. ,
Thiopurine-induced pancreatitis in inflammatory bowel diseases, Expert Rev Gastroenterol Hepatol, vol.9, pp.399-403, 2015. ,
Rituximab for ANCA-associated vasculitides, Clin Exp Rheumatol, vol.32, pp.118-139, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01064298
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis, J Neurol, vol.262, pp.1115-1124, 2015. ,
Clinical review: Serious adverse events associated with the use of rituximab-a critical care perspective, Crit Care, vol.16, p.231, 2012. ,
Severe hypertriglyceridemia in a patient with lupus, Am J Med, vol.118, pp.443-447, 2005. ,